Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 66101-66150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06714604
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
PHASE3Recruiting
432 participants
Started: Oct 18, 2023 · Completed: Dec 31, 2033
6 conditions2 sponsors1 location
NCT06404710
Progressive Muscle Relaxation Exercise Applied After Heart Surgery
NAActive, not recruiting
57 participants
Started: Oct 18, 2023 · Completed: Jun 20, 2024
1 condition1 sponsor1 location
NCT05724173
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
NARecruiting
2 participants
Started: Oct 18, 2023 · Completed: Dec 31, 2026
8 conditions2 sponsors2 locations
NCT06164756
Long Term Follow Up KET-PD
N/AEnrolling by invitation
40 participants
Started: Oct 18, 2023 · Completed: Dec 21, 2025
2 conditions3 sponsors1 location
NCT06059027
Microbes and Respiratory Illnesses
N/ARecruiting
350 participants
Started: Oct 18, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06103526
Immunonutrition in ERAS Protocols in Gynecologic Oncology
NARecruiting
200 participants
Started: Oct 18, 2023 · Completed: Aug 30, 2025
3 conditions1 sponsor1 location
NCT05483400
Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
PHASE2Recruiting
97 participants
Started: Oct 18, 2023 · Completed: Sep 30, 2027
3 conditions1 sponsor1 location
NCT06096207
DBS for Depression
PHASE1Recruiting
20 participants
Started: Oct 18, 2023 · Completed: Oct 18, 2038
1 condition2 sponsors1 location
NCT06223464
Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
N/AActive, not recruiting
130 participants
Started: Oct 18, 2023 · Completed: Apr 18, 2024
1 condition1 sponsor1 location
NCT06010251
Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain
NARecruiting
30 participants
Started: Oct 17, 2023 · Completed: Oct 20, 2026
2 conditions1 sponsor1 location
NCT06015893
Semaglutide Therapy for Alcohol Reduction (STAR)
PHASE2Recruiting
52 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05295628
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
NAActive, not recruiting
532 participants
Started: Oct 17, 2023 · Completed: Oct 1, 2025
4 conditions2 sponsors23 locations
NCT06915922
YAG Laser Vitreolysis for Vitreous Floaters
NARecruiting
50 participants
Started: Oct 17, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT06332690
OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO
N/ARecruiting
50 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05653258
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
PHASE2/PHASE3Recruiting
160 participants
Started: Oct 17, 2023 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT06679023
Wound Biofilm Detection Kit Development: Validation of Grading System With Biofilm Severity
N/AActive, not recruiting
60 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06690684
Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases
N/AEnrolling by invitation
300 participants
Started: Oct 17, 2023 · Completed: Dec 30, 2028
4 conditions1 sponsor1 location
NCT06111274
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
PHASE2Recruiting
82 participants
Started: Oct 17, 2023 · Completed: Dec 29, 2026
1 condition1 sponsor5 locations
NCT05811364
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NARecruiting
244 participants
Started: Oct 17, 2023 · Completed: Jan 31, 2032
2 conditions1 sponsor7 locations
NCT06069882
Cognitive Rehabilitation for People With Mild-to-moderate Dementia
NANot yet recruiting
18 participants
Started: Oct 17, 2023 · Completed: Mar 1, 2024
1 condition2 sponsors0 locations
NCT05366816
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
PHASE2Recruiting
48 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05879757
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
N/ARecruiting
75 participants
Started: Oct 17, 2023 · Completed: Feb 16, 2027
2 conditions1 sponsor27 locations
NCT06498830
Application of CTA-based Radiomic Phenotyping of PCAT and Fluid Dynamics in Atherosclerotic Disease (APPLE)
N/ARecruiting
2,000 participants
Started: Oct 17, 2023 · Completed: Dec 30, 2024
3 conditions1 sponsor1 location
NCT06079411
Virtual Therapeutics for MCI
NARecruiting
36 participants
Started: Oct 17, 2023 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT05889013
Utility of PCD Diagnostics to Improve Clinical Care
N/ARecruiting
50 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06152419
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
NARecruiting
25 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2024
5 conditions2 sponsors1 location
NCT05920174
Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability
NARecruiting
9 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
1 condition5 sponsors4 locations
NCT05972005
Stronger At Home: Improving Outcomes for Older Adults After Hip Fracture
NARecruiting
200 participants
Started: Oct 17, 2023 · Completed: Jul 29, 2028
1 condition1 sponsor1 location
NCT06031623
REBOA in Nontraumatic OHCA
NARecruiting
234 participants
Started: Oct 17, 2023 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT05994976
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
N/ARecruiting
500 participants
Started: Oct 17, 2023 · Completed: Aug 31, 2028
6 conditions1 sponsor1 location
NCT05870761
Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma
PHASE2Active, not recruiting
8 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05898659
Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting With or Without Synchronization
NARecruiting
20 participants
Started: Oct 17, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT05874063
Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
PHASE3Recruiting
387 participants
Started: Oct 17, 2023 · Completed: Feb 29, 2028
1 condition1 sponsor26 locations
NCT05885646
Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
N/ARecruiting
15 participants
Started: Oct 17, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor3 locations
NCT06120023
Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison
N/ARecruiting
1,000 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2040
1 condition1 sponsor1 location
NCT05906511
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults
EARLY_PHASE1Recruiting
20 participants
Started: Oct 17, 2023 · Completed: Aug 31, 2026
3 conditions3 sponsors1 location
NCT06268717
GI Alpha-Gal Study
NARecruiting
30 participants
Started: Oct 17, 2023 · Completed: Jun 2, 2026
5 conditions2 sponsors1 location
NCT06086444
Tranexamic Acid in Abdominoplasty.
PHASE4Recruiting
60 participants
Started: Oct 17, 2023 · Completed: Dec 1, 2024
3 conditions1 sponsor1 location
NCT06588231
Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
NARecruiting
200 participants
Started: Oct 17, 2023 · Completed: Aug 17, 2025
1 condition1 sponsor1 location
NCT06753617
Cryoablation of Brain Neoplasm
NAEnrolling by invitation
20 participants
Started: Oct 17, 2023 · Completed: May 31, 2025
4 conditions2 sponsors1 location
NCT06049095
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
PHASE1Active, not recruiting
96 participants
Started: Oct 17, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05853601
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
PHASE1/PHASE2Recruiting
30 participants
Started: Oct 17, 2023 · Completed: Apr 1, 2027
2 conditions2 sponsors1 location
NCT05450159
The Refreshing Older Adults' Driving Skills (ROADSkills) Program
NARecruiting
30 participants
Started: Oct 17, 2023 · Completed: Jul 31, 2024
1 condition2 sponsors1 location
NCT06094400
Pain and Stress Detection and Relief in People With Dementia
NANot yet recruiting
60 participants
Started: Oct 17, 2023 · Completed: Jun 30, 2024
3 conditions1 sponsor0 locations
NCT06117241
Reducing Metabolic Dysregulation in Dyads
NARecruiting
180 participants
Started: Oct 17, 2023 · Completed: Mar 31, 2028
3 conditions1 sponsor1 location
NCT06347029
"Evaluation of Endothelial Dysfunction Using the Flow Mediated Dilation Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies"
NARecruiting
200 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05794035
Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients
NARecruiting
303 participants
Started: Oct 17, 2023 · Completed: Mar 1, 2028
1 condition1 sponsor1 location
NCT04859218
Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?
NARecruiting
30 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05826314
Boxing Training, Physical-functional Fitness and Cognitive Performance in Older Adults
NAActive, not recruiting
75 participants
Started: Oct 17, 2023 · Completed: Aug 1, 2025
1 condition3 sponsors1 location
NCT05100121
To Live Better After Prostate Cancer Treatment:
NARecruiting
40 participants
Started: Oct 17, 2023 · Completed: Dec 25, 2025
1 condition1 sponsor1 location